Status:
UNKNOWN
Epidural Stimulation After Spinal Cord Injury
Lead Sponsor:
McGuire Research Institute
Conditions:
Spinal Cord Injuries
Eligibility:
All Genders
18-70 years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of the current study is to determine the effects of applying epidural stimulation (ES) on motor control recovery in Veterans with SCI. The intervention will be accompanied with the use of ...
Detailed Description
Five veterans with chronic motor complete SCI (AIS A or B) will be recruited to participate in the current trial. The primary objective is to determine how implantation of an epidural stimulator can h...
Eligibility Criteria
Inclusion
- A written clearance by the medical doctor to ensure that the participant is safely able to engage in the program.
- Participants who require assistance with activities of daily living, must have a caregiver or companion with them throughout their participation in the study.
- Participants will have to be 2 years post-injury with any level of injury below C5 and using wheelchair as the primary mode of mobility. The study is primarily exploratory, and all participants will be between 18-70 years old with SCI.
- Hip width (distance between two greater trochanters), upper leg length (greater trochanter to the lateral aspect of joint line of the knee joint) and lower leg length (lateral aspect of joint line of the knee joint to the bottom of the foot) that can fit the robotic suit.
Exclusion
- Unhealed fracture in either lower or upper extremities
- Severe scoliosis, hip knee ROM or flexion knee contractures preventing positioning in an exoskeleton or plantarflexion deformity greater than 20 degrees.
- High resting blood pressure greater than 140/80 mmHg and or sudden hypotension upon standing as characterized by drop in blood pressure by 20 mmHg especially in persons with tetraplegia.
- Other medical conditions including cardiovascular disease, uncontrolled type II DM, uncontrolled hypertension, and those on insulin, pressures sores stage 3 or greater, or symptomatic urinary tract infection.
- Unable to fit in the device for any reason.
- Taking anti-coagulants or anti-platelet agents, including aspirin if unable to be off this medication for medical reasons.
- Implanted pacemakers and/or implanted defibrillator devices.
- Any condition that, in the judgment of the principal investigator or medical provider, precludes safe participation in the study and/or increases the risk of infection.
- Dual Energy X-ray Absorptiometry (DXA) T-Score less than -2.5. Scans done will include total body, dual hips and knees.
- Functional upper and lower extremity range of motion (ROM), strength, spasticity and skin integrity will also have assessed prior to enrollment in the program. The Modified Ashworth Scale will be used to ensure safety of the participants prior to engagement in the rehabilitation program. Participants with severe spasticity or limited ROM will be excluded in the trial. This will be done based on the manufacture's recommendation.
- Other exclusion criteria may include the followings
- subjects with uncontrolled autonomic dysreflexia
- subjects with concurrent severe neurological injuries other than SCI: MS, CP, TBI, stroke;
- subjects with unresolved deep vein thrombosis (DVT);
- subjects with prosthetic lower limbs;
- subjects with psychiatric or cognitive impairments which will interfere with proper operation of both the spinal cord stimulator as well as the exoskeleton;
- subjects with an unhealed spinal fracture or unstable spine; and
- subjects with known cardiac pathology which precludes safe participation
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2021
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT04105296
Start Date
January 1 2020
End Date
December 30 2021
Last Update
October 3 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hunter Holmes McGuire VA Medical Center
Richmond, Virginia, United States, 23249